Author
National Institutes of HealthORCID 0000-0002-6675-1531Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Brett Schroeder, Jae Choi, Alejandro A. Schäffer…·Anish Thomas
The paper identifies CLDN3 as a tumor-selective target in SCLC using proteogenomic analysis and validates its therapeutic potential with a monoclonal antibody.
Azam Ghafoor, Linying Zhu, Zoë Weaver Ohler…·Yilun Sun
This study shows that HDAC inhibition with entinostat enhances immunotherapy response in SCLC by reprogramming tumor immunology and neuroendocrine status.
Parth Anil Desai, Nobuyuki Takahashi, Rajesh Kumar…·Anish Thomas
This study maps the SCLC tumor microenvironment and identifies cancer-associated fibroblasts as key drivers of neuroendocrine state plasticity and poor prognosis.